Table 4.
Surface plasmon resonance analysis of bispecific antibody binding affinity to human EGFR.
| Compound | Analyte | ka [M−1 s−1] | kd [s−1] | KD [M] |
|---|---|---|---|---|
| XGFR | huEGFR | 7.3E + 04 | 4.6E-04 | 6.4E-09 |
| XGFR* | huEGFR | 7.6E + 04 | 4.9E-04 | 6.4E-09 |
Surface plasmon resonance analysis of bispecific antibody binding affinity to human EGFR.
| Compound | Analyte | ka [M−1 s−1] | kd [s−1] | KD [M] |
|---|---|---|---|---|
| XGFR | huEGFR | 7.3E + 04 | 4.6E-04 | 6.4E-09 |
| XGFR* | huEGFR | 7.6E + 04 | 4.9E-04 | 6.4E-09 |